Specify a stock or a cryptocurrency in the search bar to get a summary
Shanghai Yizhong Pharmaceutical Co Ltd
688091Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. The company develops paclitaxel polymer micelle for treatment of small cell lung cancer. Shanghai Yizhong Pharmaceutical Co., Ltd. was founded in 2009 and is headquartered in Shanghai, China. Address: No.79 Renqi Road, Shanghai, China, 201403
Analytics
WallStreet Target Price
615.41 CNYP/E ratio
333.6923Dividend Yield
0.73 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688091
Dividend Analytics 688091
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
23 %Dividend History 688091
Stock Valuation 688091
Financials 688091
Results | 2019 | Dynamics |